Navigation Links
The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant
Date:3/15/2011

SAN FRANCISCO, March 15, 2011 /PRNewswire/ -- Motion Therapeutics, Inc. http://www.motiontherapeutics.com, the leading provider of noninvasive therapeutic solutions for balance and mobility disorders, today announced that researchers at Samuel Merritt University and San Francisco State received a NIH Recovery Act Grant to study the effects of wearing a strategically weighted vest to improve gait and mobility in people with MS.

This grant comes after the completion of a similar randomized controlled trial which was funded by the National MS Society. The NIH study, being led by Drs. Gail Widener, PT, Ph.D and Diane Allen, PT, Ph.D utilizes the BalanceWear technology invented by Cynthia Gibson-Horn, PT.

"Patients with MS suffer from imbalance and decreased mobility resulting in adverse quality of life changes," said Gibson-Horn. "In clinical practice I noticed patients having specific balance losses while struggling to complete daily tasks. I developed the BBTW method and stabilizing garment to help patients rebalance and regain control. The NIH study will provide more scientific evidence supporting this balance treatment." Gibson-Horn has worked with strategic BBTW™ treatment therapy with over 400 patients.

"We are delighted by the dramatic patient balance and mobility improvements achieved when utilizing our BBTW treatment therapy," said Steve Cookston, Motion Therapeutics' CEO. The therapy relies on a trained clinician performing the BBTW™ assessment test and utilizing the BalanceWear vest to strategically place light weights on the torso of the body.

Meet Cynthia Gibson-Horn, PT, inventor of the BBTW™ treatment therapy in New York at the Annual MS Family Discovery Day on March 19, 2011. Motion Therapeutics will be providing live demonstrations. Schedule an appointment with Cynthia by emailing cindy@motiontherapeutics.com.

Gibson-Horn will also be teaching the BBTW™ method to therapists at the International MS Center in New York on March 20, 2011. To sign up please visit: http://www.motiontherapeutics.com/seminars. Input MTI100 to receive priority registration.

About Motion Therapeutics, Inc.

Motion Therapeutics, Inc., developers of the BalanceWear range of therapeutic garments, provides noninvasive therapeutic solutions for balance and mobility disorders caused by MS, Parkinson's, Head Trauma, Osteoporosis, and Ataxia, to name a few. Balance-Based Torso-Weighting® is a proprietary evaluation and treatment therapy designed by Cynthia Gibson-Horn, PT in 2004. Motion Therapeutics, Inc. was founded in 2010 and has offices in Oakland, Oxnard and San Francisco.


'/>"/>
SOURCE Motion Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Los Angeles Dentist, Dr. Kevin Sands, Uses the Latest Technologies to Provide VIP Services and Treatments for His Patients
2. International Prostate Cancer Treatment Expert Dr. David B. Samadi Supports Kenyan Minister of Medical Services, Peter Anyang Nyongos Decision to Travel to the U.S. for Prostate Cancer Treatment
3. Practice Guidelines Confirm Utility of Endoscopic Radiofrequency Ablation (RFA) for the Treatment of Barretts Esophagus
4. Pew Applauds Introduction of Preservation of Antibiotics for Medical Treatment Act of 2011
5. Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older
6. Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic Cancer
7. Reportlinker Adds Aesthetic Devices Market to 2017 - Future Growth to be Driven by Improving Treatment Outcomes and Increase in Consumer Confidence
8. FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
9. Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
10. OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference
11. FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
Breaking Medicine News(10 mins):